Eventide Asset Management’s Centessa Pharmaceuticals CNTA Stock Holding History

Eventide Asset Management’s Portfolio CNTA Stock Details CNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-668,142	Closed	-$26.5M	–	307
2026 Q1	$26.5M	Buy	+668,142	New	+$17.1M	0.44%	80

Eventide Asset Management's CNTA Position: Q2 2026 in Review

Eventide Asset Management sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 668,142 shares — an estimated $26.5M sold.

Eventide Asset Management first reported a position in CNTA in Q1 2026 and held it in 1 quarter. The position peaked at $26.5M in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

Eventide Asset Management reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Eventide Asset Management sold 668,142 Centessa Pharmaceuticals shares in Q2 2026, an estimated $26.5M.
Eventide Asset Management first reported a position in Centessa Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Eventide Asset Management's Centessa Pharmaceuticals position peaked at $26.5M in Q1 2026.
0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on Eventide Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.